Order Article Reprints

Yegodayev KM, Novoplansky O, Golden A, Prasad M, Levin L, Jagadeeshan S, Zorea J, Dimitstein O, Joshua B-Z, Cohen L, et al. TGF-Beta-Activated Cancer-Associated Fibroblasts Limit Cetuximab Efficacy in Preclinical Models of Head and Neck Cancer. Cancers. 2020; 12(2):339. https://doi.org/10.3390/cancers12020339

Yegodayev, Ksenia M., Ofra Novoplansky, Artemiy Golden, Manu Prasad, Liron Levin, Sankar Jagadeeshan, Jonathan Zorea, Orr Dimitstein, Ben-Zion Joshua, Limor Cohen, and et al. 2020. "TGF-Beta-Activated Cancer-Associated Fibroblasts Limit Cetuximab Efficacy in Preclinical Models of Head and Neck Cancer" Cancers 12, no. 2: 339. https://doi.org/10.3390/cancers12020339

Yegodayev, K. M., Novoplansky, O., Golden, A., Prasad, M., Levin, L., Jagadeeshan, S., Zorea, J., Dimitstein, O., Joshua, B.-Z., Cohen, L., Khrameeva, E., & Elkabets, M. (2020). TGF-Beta-Activated Cancer-Associated Fibroblasts Limit Cetuximab Efficacy in Preclinical Models of Head and Neck Cancer. Cancers, 12(2), 339. https://doi.org/10.3390/cancers12020339